Drawing for CRISPRBIOME

USPTO serial 90341701

CRISPRBIOME

Reviewed by CopyMark Law Group

Reg. 6727299Status 700Registered
Filing date
Status date
Registration date
May 24, 2022
Examiner
RINGLE, JAMES W
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CRISPRBIOME?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Stacy J. Grossman

Stacy J. Grossman LAW OFFICE OF STACY J. GROSSMAN PLLC500 MAMARONECK AVENUE, SUITE 320HARRISON, NY 10528UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations, namely, antibacterial treatments, microbiome modulating treatments, anti-infective treatments and prophylaxis; medical preparations, namely, antibacterial treatments, microbiome modulating treatments, anti-infective treatments and prophylaxis, and medical diagnostics; veterinary preparations for antibacterial treatments, microbiome modulating treatments, anti-infective treatments and prophylaxis, and medical diagnostics; sanitary preparations for medical purposes; dietetic food and beverages adapted for medical or veterinary use; dietary supplements for human beings and animals; dietary supplements; antibiotic preparations; pharmaceutical preparations, namely, antiviral preparations; probiotic supplements; probiotic supplements for medical use; probiotic formulations for veterinary use, namely, probiotic nutritional supplements; probiotic formulations for medical use, namely, probiotic nutritional supplements; enzymes of microbiome modulators for veterinary purposes, namely, animal feed additives for use in animals feed to assist in digestion; enzymes of microbiome modulators for medical purposes, namely, targeted antimicrobial treatments for disease prevention or alteration; guided nuclease-based biocides; pharmaceutical preparations for the treatment or prevention of disorders or diseases caused by bacteriaACTIVE—
042Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific and technological services, namely, scientific research, analysis and testing in the field of diseases and conditions associated with bacteria; industrial analysis and industrial research services; design and development of computer hardware and software; genetic microbiology and microbiome research; genetic engineering and services; design and development of hardware and software; clinical research; pharmaceutical research and development; development of pharmaceutical preparations and medicines; research and development services in the field of antibiotics; research and development of guided nuclease-based biocides; conducting clinical trials for others; clinical research; conducting clinical trials for pharmaceutical products; bacteriological research; viral research; biological research; scientific and medical screening and assaying; chemical analysis; chemical researchACTIVE—
044Medical services; diagnostic and prognostic medical services; veterinary services; medical analysis services relating to the treatment of persons in the nature of diagnostic and treatment counselling regarding the treatment of conditions and disease; pharmaceutical advice; medical and health services relating to DNA, genetics and genetic pathogen testing, namely, genetic testing for medical purposes; genetic counselling; medical screening and assayingACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 24, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 24, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 1, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 1, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 9, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 24, 2022FIXDELECTRONIC RECORD REVIEW COMPLETE—
Jan 7, 2022ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Jan 3, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 24, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 23, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 23, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 17, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 17, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 17, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 4, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 4, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 28, 2021ALIEASSIGNED TO LIE—
Oct 22, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 26, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 26, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 26, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 8, 2021DOCKASSIGNED TO EXAMINER—
Jan 30, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 28, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance